2,3,5-TRI-O-BENZOYL-ALPHA-D-ARABINOFURANOSYL-(1->5)-2,6-DI-O-PIVALOYL-D-GALACTONO-1,4-LACTONE
Compound with spectra: 1 NMR
| SpectraBase Compound ID | GKKynTFZ0Nz |
|---|---|
| InChI | InChI=1S/C42H46O15/c1-41(2,3)39(48)51-23-27(30-29(43)32(37(47)54-30)57-40(49)42(4,5)6)52-38-33(56-36(46)26-20-14-9-15-21-26)31(55-35(45)25-18-12-8-13-19-25)28(53-38)22-50-34(44)24-16-10-7-11-17-24/h7-21,27-33,38,43H,22-23H2,1-6H3/t27-,28+,29+,30+,31+,32-,33-,38-/m1/s1 |
| InChIKey | OPZYMGRJDRALCA-WIBPCEESSA-N |
| Mol Weight | 790.8 g/mol |
| Molecular Formula | C42H46O15 |
| Exact Mass | 790.283671 g/mol |
| Enantiomer InChIKey | OPZYMGRJDRALCA-ZUWKLVTASA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
OCTYL-2,3,6-TRI-O-BENZYL-5-(2,3,5-TRI-O-BENZOYL-ALPHA-D-ARABINOFURANOSYL)-BETA-D-GALACTOFURANOSIDE
3-O-(2,3,4,6-TETRA-O-BENZOYL-BETA-D-GLUCOPYRANOSYL)-D-GLUCOPYRANOSIDE;MIXTURE
METHYL-5-O-(2,3-DI-O-BENZOYL-5-O-CHLOROACETYL-6-O-PIVALOYL-BETA-D-GALACTOFURANOSYL)-2,3-DI-O-BENZOYL-6-O-PIVALOYL-BETA-D-GALACTOFURANOSIDE
METHYL-5-O-(2,3-DI-O-BENZOYL-6-O-PIVALOYL-BETA-D-GALACTOFURANOSYL)-2,3-DI-O-BENZOYL-6-O-PIVALOYL-BETA-D-GALACTOFURANOSIDE
HCTASHKKGRBEOB-GCBBWRJDSA-N
QTGPIKQIPRBHDP-QUVSIAOLSA-N
METHYL-2,3,4,6-TETRA-O-BENZOYL-BETA-D-GLUCOPYRANOSYL-(1->6)-2,3,4-TRI-O-BENZOYL-BETA-D-GLUCOPYRANOSYL-(1->6)-BETA-D-GLUCOPYRANOSIDE
PHLOROGLUCINOL-BETA-D-GLUCOSIDE_HEXABENZOATE
2,6-DIMETHOXYPHENOL-2,3,4,6-TETRA-O-BENZOYL-BETA-D-GALACTOPYRANOSIDE
Methyl-2,3,4-tri-O-benzoyl-6-O-(2,3,4-tri-O-pivaloyl-b-d-glucopyranosyl)-a-d-glucopyranoside
| Title | Journal or Book | Year |
|---|---|---|
|
Facile synthesis of α- |
Canadian Journal of Chemistry | 2006 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.